Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Quality Systems, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, an electronic health records solution, which stores and maintains clinical patient information; and offers a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its principal products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health Solutions and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. The company serves multi-specialty and small single specialty practices, including physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. Quality Systems, Inc. was founded in 1974 and is headquartered in Irvine, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Dec '15 Mar '16 Dec '16 Mar '17 Dec '17 Mar '18
Equity (BVPS) 3.87
4.77
5.39
4.98
4.68
4.66
4.77
5.17
growth rate 23.3% 13.0% -7.6% -6.0% -0.2% 1.2% 4.1%
Earnings BIT 94.42
116.31
68.91
23.00
37.89
18.52
39.94
23.86
38.34
25.18
26.19
growth rate 23.2% -40.8% -66.6% 64.8% -51.1% 115.7% -40.2% 60.7% -34.3% 4.0%
Avg.PE 39.37
34.13
25.45
64.94
35.20
26.28
-302.87
50.21
61.43
growth rate -13.3% -25.4% 155.2% -45.8% -13.6% -100.0% 100.0% 22.4%
ROA 17.89
18.47
9.67
3.53
6.04
1.14
3.63
0.49
growth rate 3.2% -47.6% -63.5% 71.1% -56.6% 78.4% -63.3%
ROE 29.84
29.11
14.19
5.21
9.45
2.05
6.35
0.77
growth rate -2.5% -51.3% -63.3% 81.4% -53.4% 76.0% -65.2%
ROIC 29.75
29.05
14.19
5.21
9.45
1.69
5.95
1.41
growth rate -2.4% -51.2% -63.3% 81.4% -57.7% 87.6% -51.3%
Cur. Ratio 2.07
2.41
2.34
2.10
1.81
1.33
1.14
1.05
growth rate 16.4% -2.9% -10.3% -13.8% -14.3% -7.4% -4.0%
Quick Ratio 1.88
2.22
2.10
1.88
1.56
1.18
0.96
0.91
growth rate 18.1% -5.4% -10.5% -17.0% -13.0% -9.8% -2.6%
Leverage 1.69
1.49
1.44
1.51
1.62
1.97
1.55
1.59
growth rate -11.8% -3.4% 4.9% 7.3% 10.3% -11.3% 1.3%
Balance Sheet Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Dec '15 Mar '16 Dec '16 Mar '17 Dec '17 Mar '18
Acct.Receivable 139.80
158.51
160.40
143.17
110.82
15.89
126.73
16.78
86.09
16.47
93.08
growth rate 13.4% 1.2% -10.7% -22.6% -85.7% 697.6% -86.8% 413.0% -80.9% 465.1%
Acct.Payable 26.76
35.31
34.53
10.02
8.74
11.13
9.11
4.62
9.36
4.21
growth rate 32.0% -2.2% -71.0% -12.7% 27.3% -18.1% -49.3% 102.7% -55.0%
Cur.Assets 282.40
312.71
297.33
273.29
255.98
91.96
183.99
105.04
146.80
118.02
141.66
growth rate 10.7% -4.9% -8.1% -6.3% -64.1% 100.1% -42.9% 39.8% -19.6% 20.0%
Total Assets 378.70
440.35
443.06
451.35
460.52
196.50
530.79
210.16
473.22
228.45
515.76
growth rate 16.3% 0.6% 1.9% 2.0% -57.3% 170.1% -60.4% 125.2% -51.7% 125.8%
Cash 116.60
136.41
111.49
107.50
118.99
59.93
27.18
74.71
37.67
85.00
28.85
growth rate 17.0% -18.3% -3.6% 10.7% -49.6% -54.7% 174.9% -49.6% 125.6% -66.1%
Inventory 1.90
1.24
0.71
0.83
0.62
14.73
0.56
12.43
0.16
13.55
0.18
growth rate -34.6% -42.8% 17.5% -25.4% 2,267.9% -96.2% 2,140.2% -98.7% 8,473.4% -98.7%
Cur.Liabilities 136.60
129.43
127.03
126.97
155.08
8.74
138.06
9.11
128.69
9.36
134.59
growth rate -5.3% -1.9% 0.0% 22.1% -94.4% 1,479.3% -93.4% 1,313.0% -92.7% 1,338.1%
Liabilities 154.00
145.18
136.01
156.26
176.98
29.87
261.41
30.52
168.18
23.19
192.35
growth rate -5.7% -6.3% 14.9% 13.3% -83.1% 775.1% -88.3% 451.0% -86.2% 729.3%
LT Debt 0.00
0.00
0.00
105.00
105.00
105.00
15.00
37.00
growth rate 0.0% 0.0% -62.2% 57.1%
Equity 224.70
295.18
307.05
295.09
283.54
166.63
269.38
179.64
305.04
205.25
323.41
growth rate 31.4% 4.0% -3.9% -3.9% -41.2% 61.7% -33.3% 69.8% -32.7% 57.6%
Common Shares 58.00
59.00
59.00
60.00
0.60
0.66
0.61
0.66
0.63
0.66
0.64
growth rate 1.7% 0.0% 1.7% -99.0% 8.6% -6.9% 7.7% -4.9% 5.4% -2.9%
Cash Flow Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Dec '15 Mar '16 Dec '16 Mar '17 Dec '17 Mar '18
Capital Expenditures 6.50
10.32
9.97
7.93
6.53
11.46
14.01
17.66
12.17
21.34
9.80
growth rate 58.8% -3.4% -20.4% -17.7% 75.5% 22.3% 26.1% -31.1% 75.4% -54.1%
Cash Dividends 34.70
40.99
41.54
42.20
42.77
2.80
42.85
2.78
3.01
growth rate 18.1% 1.3% 1.6% 1.3% -93.5% 1,431.5% -93.5% 4.1%
Cash From OA 70.30
78.11
68.07
104.05
82.76
32.49
40.80
37.85
110.59
34.28
76.59
growth rate 11.1% -12.9% 52.9% -20.5% -60.7% 25.6% -7.2% 192.2% -69.0% 123.4%
FCF per Share 0.79
0.75
0.66
0.92
1.22
0.39
1.18
0.93
growth rate -5.1% -12.0% 39.4% 32.6% -43.5% 73.9% -11.2%
Sale Purchase of Stock 12.79
0.95
2.20
0.38
-0.38
0.99
-2.77
1.31
-0.24
4.89
growth rate -92.6% 132.1% -82.6% -100.0% 100.0% -100.0% 100.0% -100.0% 100.0%
FCF 46.00
66.00
29.00
75.40
61.60
21.04
12.10
20.18
90.20
12.95
47.90
growth rate 43.5% -56.1% 160.0% -18.3% -65.9% -42.5% 66.8% 346.9% -85.7% 270.0%
Income Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Dec '15 Mar '16 Dec '16 Mar '17 Dec '17 Mar '18
Sales 353.40
429.84
460.23
444.67
490.23
130.84
492.48
139.28
509.62
144.84
531.02
growth rate 21.6% 7.1% -3.4% 10.3% -73.3% 276.4% -71.7% 265.9% -71.6% 266.6%
Op.Income 94.10
75.66
42.72
23.09
37.89
19.09
39.94
23.48
38.34
24.23
26.19
growth rate -19.6% -43.5% -46.0% 64.1% -49.6% 109.2% -41.2% 63.3% -36.8% 8.1%
IBT 94.40
116.31
68.91
23.00
35.66
17.48
6.32
23.62
23.61
24.94
-0.41
growth rate 23.2% -40.8% -66.6% 55.1% -51.0% -63.9% 273.7% 0.0% 5.7% -100.0%
Net Income 61.60
75.66
42.72
15.68
27.33
12.89
5.66
17.75
18.24
27.15
2.42
growth rate 22.8% -43.5% -63.3% 74.3% -52.9% -56.1% 213.8% 2.7% 48.8% -91.1%
EPS 1.06
1.28
0.72
0.26
0.45
0.09
0.29
0.04
growth rate 20.8% -43.8% -63.9% 73.1% -55.3% 79.5% -62.9%
Gross Profit 225.90
278.61
270.58
224.50
267.06
28.71
266.86
33.09
286.49
34.38
289.48
growth rate 23.3% -2.9% -17.0% 19.0% -89.3% 829.4% -87.6% 765.7% -88.0% 742.0%
R&D 21.80
31.37
30.87
41.52
69.24
65.66
78.34
81.26
growth rate 43.9% -1.6% 34.5% 66.8% -2.6% 9.2% 1.9%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 6.74
11.34
3.92
4.20
6.52
growth rate 68.2% -65.5% 7.1% 55.3%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 83.91
84.58
83.50
93.08
104.19
growth rate 0.8% -1.3% 11.5% 11.9%
Acct.Payable 5.01
6.81
3.07
4.21
3.13
growth rate 36.1% -55.0% 37.3% -25.6%
Cur.Assets 131.54
133.14
128.35
141.66
155.81
growth rate 1.2% -3.6% 10.4% 10.0%
Total Assets 489.91
514.06
501.38
515.76
535.14
growth rate 4.9% -2.5% 2.9% 3.8%
Cash 23.34
26.55
23.36
28.85
26.54
growth rate 13.8% -12.0% 23.5% -8.0%
Inventory 0.10
0.15
0.15
0.18
0.16
growth rate 47.0% 4.8% 16.9% -10.6%
Cur.Liabilities 105.75
108.61
107.96
134.59
135.07
growth rate 2.7% -0.6% 24.7% 0.4%
Liabilities 175.72
188.56
170.64
192.35
198.24
growth rate 7.3% -9.5% 12.7% 3.1%
LT Debt 45.00
55.00
39.00
37.00
44.00
growth rate 22.2% -29.1% -5.1% 18.9%
Equity 314.19
325.50
330.74
323.41
336.89
growth rate 3.6% 1.6% -2.2% 4.2%
Common Shares 0.63
0.64
0.64
0.64
0.64
growth rate 0.5% 0.0% 0.5% 0.3%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 2.47
2.95
2.18
2.20
2.18
growth rate 19.5% -26.1% 0.6% -0.7%
Cash Dividends 0.75
0.75
0.75
0.76
growth rate 0.0% 0.1% 0.1%
Cash From OA 12.79
25.30
18.68
19.81
3.01
growth rate 97.8% -26.2% 6.1% -84.8%
Sale Purchase of Stock 3.97
0.35
0.33
0.25
1.35
growth rate -91.2% -5.4% -24.8% 443.0%
FCF 10.32
22.35
16.50
17.62
0.83
growth rate 116.5% -26.2% 6.8% -95.3%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 130.92
132.61
131.72
135.78
133.20
growth rate 1.3% -0.7% 3.1% -1.9%
Op.Income 6.74
11.34
3.92
4.20
6.52
growth rate 68.2% -65.5% 7.1% 55.3%
IBT 6.05
10.52
3.03
-20.01
3.09
growth rate 73.9% -71.2% -100.0% 100.0%
Net Income 3.90
8.03
1.54
-11.05
2.65
growth rate 106.1% -80.8% -100.0% 100.0%
EPS
growth rate
Gross Profit 71.75
73.85
70.08
73.80
77.89
growth rate 2.9% -5.1% 5.3% 5.6%
R&D 19.99
19.53
20.65
21.10
21.53
growth rate -2.3% 5.7% 2.2% 2.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (18.66)

YOY Growth Grade:

E (17.30)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 1,241.67 1,241.67 26.29
EPS / Growth -0.2% 0.02 8.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 6.7% 6.7%
Future PE 2.00 19.82 19.82
Future EPS 0.02 0.03 0.03
Value Price
MOS %
0.01
0.17
0.17
MOS Price 0.00 0.08 0.08
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.